HTA Senior Manager

Jobs at G&J Lee Recruitment for Health Economists

London, UK. UK Pharma company vacancy. Oncology product portfolio. Focus on UK & Ireland HTA submissions. Hybrid role – 1/2 days per week within West London HQ. Excellent salary (£100k+), 20% bonus, car allowance and comprehensive benefits package. This is a senior position within the UK & Ireland business unit of a global Pharma company, focusing on the development and … Read more

Director, In-line Brands – Global Health Economics, Value, and Outcomes

Teva pharmaceuticals health economics jobs

Parsippany, NJ, US. The ideal candidate will be based out of our Parsippany, New Jersey office. As the Director, In-line Brands – Global health Economics, Value, and Outcomes, you will serve as the principal strategic and technical lead for our Neuroscience TA, primarily focused on the US market. You will develop and implement comprehensive evidence generation plans, including clinical, economic … Read more

Senior Scientific Writer – Health Economics and Value Assessment

Sanofi Health Economists jobs

Hyderabad, India. The overall purpose and main responsibilities are listed below: Create HEVA communications deliverables (including manuscripts, posters, abstracts, slide decks) aligned with HEVA strategy and global HEVA communication plan across relevant business units and product teams. Manage core HEVA communication processes, templates, and products across the portfolio in accordance with the scientific and value messages aligned with Core Value … Read more

RWE Associate Director

Vertex Health Economics jobs

Boston, MA, US. The Real World Evidence (RWE) Associate Director is an integral member of the RWE team, who leverages expertise in epidemiology and real world data to develop fit-for-purpose observational research, and to inform internal and external stakeholders on natural history (NH) of disease and real world outcomes within their assigned therapeutic area. The RWE Associate Director works cross-functionally … Read more

Manager HEOR

Jobs at Philips Healthcare for Health Economists

Cambridge, MA / Bothell, WA, US. Other locations: Colorado Springs, CO; Nashville, TN; Plymouth, MN; San Diego, CA, US. You will generate HEOR real-world evidence to drive patient access to diverse innovations from Philips businesses being part of the global Health Economics team within the Health Economics, Market Access, and Reimbursement Department. In this role you will be responsible for: … Read more

HEOR & RWE Manager

Jobs at Bayer for Health Economists

Diegem, Belgium / Hoofddorp, Netherlands. The combined Market Access/Regulatory Affairs department is key in bringing medical innovations to patients in the Benelux. These patients count on us. The Health Economics and Outcomes Research (HEOR) & Real World Evidence (RWE) Manager Benelux contributes by creating Budget Impact and Health Economic (BI&HE) models and will be in the lead for RWE collections … Read more

European HEOR & RWE Senior Manager

Jobs at Daiichi Sankyo for Health Economists

Europe. We are seeking highly qualified candidates to fill the position: European Health Economics Outcomes Research & Real World Evidence Senior Manager Oncology (m/f/x). The Position: The Senior Manager HEOR & RWE leads the development of the European HEOR and RWE strategy for the product(s) he/she is responsible for, in order to maximize the outcomes in terms of Market Access … Read more

Health Economics & RWE Manager

Jobs at Bayer for Health Economists

Diegem, Belgium / Hoofddorp, Netherlands. The combined Market Access/Regulatory Affairs department is key in bringing medical innovations to patients in the Benelux. These patients count on us. The Health Economics and Outcomes Research (HEOR) & Real World Evidence (RWE) Manager Benelux contributes by creating Budget Impact and Health Economic (BI&HE) models and will be in the lead for RWE collections … Read more

HEMA & Reimbursement Manager

Jobs for health economists at Johnson & Johnson

High Wycombe, UK. Johnson & Johnson is recruiting for a Health Economics, Market Access, & Reimbursement Manager located in High Wycombe, United Kingdom. Role Summary: The purpose of the role is to deliver accelerated, broad market and patient access and funding for our key brands. The successful candidate will play a key role as part of the HEMAR team (Health … Read more

Senior Director, RWE Innovation Methods & External Partnerships

Gilead jobs for Health Economists

Foster City, CA / Raleigh, NC, US. Other location: Parsippany, NJ, US. The Real-World Evidence (RWE) function at Gilead is part of the Clinical Data Sciences (CDS) group within the Clinical Development organization and aims to unlock the power of Real-World Data (RWD) to help transform innovations to life-changing medicines for patients. The Senior Director, RWE Innovation Methods and External … Read more

Sr. Manager, Vaccines RWE Scientist

Pfizer Health Economists jobs

New York City, NY / Collegeville, PA, US. Other location: Cambridge, MA, US. The Global Scientific Affairs COVID & Flu team is on the cutting edge of evidence generation for COVID-19 & flu vaccines, therapeutics and diagnostics. Within the Global Scientific Affairs COVID & Flu team, a dedicated team of RWE Scientists reporting to the COVID & Flu Databases Team … Read more

Fellowship – RWE / Clinical Data Science & Evidence

Jobs at Novo Nordisk for Health Economists

Plainsboro, NJ, US. The Novo Nordisk Real World Evidence (RWE) / Clinical Data Science & Evidence (CDSE) – Fellow is responsible for supporting planning and execution of observational research / Real World Evidence studies to support the Evidence and Insights Generation Plans (EIGPs) for specific areas of the Novo Nordisk portfolio. In addition, the incumbent may also coordinate other activities … Read more

Analyst – Assoc Consultant, HEOR, Real World Solutions

Health Economists jobs at IQVIA

Petaling Jaya, Malaysia / Bangkok, Thailand. Other location: Jakarta, Indonesia. Our HEOR team includes highly qualified multi-disciplinary experts. They are based throughout Asia with a focused footprint in the SEA. The HEOR practice is part of the IQVIA Real-World Insights business unit that connects healthcare stakeholders through knowledge, skills, practical experience, creativity and data to demonstrate the value of medicines, … Read more

Senior Consultant, Evidence Synthesis, RWE

Health Economists jobs at IQVIA

Mississauga, Canada. Les conseillers principaux sont des responsables de l’exécution de projets chargés de mettre en œuvre une recherche de synthèse des données probantes méthodologiquement rigoureuse, de superviser le travail du personnel subalterne et de gérer l’ensemble du projet. Ils travaillent de manière indépendante et en équipe, agissent sur les besoins anticipés du projet et les problèmes à résoudre. Le … Read more

Internship in RWE Methodology

MSD Health Economics jobs

Zurich, Switzerland. The program will be limited to EU/EFTA citizens. Are you looking for an internship to learn and develop and take a peek into the professional world while bringing in your individual contribution? Would you like to experience working in one of the biggest multinationals in the pharmaceutical industry? We are looking for a graduating/graduated master’s or PhD student … Read more

Real-World Evidence in Health Economics

RWE jobs in Health Economics
Real-World Evidence in Health Economics

Real-world evidence (RWE) has become an increasingly important aspect of health economics research in recent years. It provides a comprehensive and in-depth understanding of how different health interventions work in real-world settings.

What is Real-World Evidence?

Real-world evidence (RWE) is defined as data collected from sources other than traditional randomized controlled trials (RCTs). These data come from a variety of sources, including electronic health records (EHRs), claims databases, registries, patient-reported outcomes (PROs), and surveys.

RWE allows researchers to evaluate the effectiveness, safety, and cost-effectiveness of health interventions in real-world settings. This is important because RCTs often have strict inclusion and exclusion criteria, which means that the results may not be generalizable to real-world populations.

Importance of Real-World Evidence in Health Economics

RWE is becoming increasingly important in health economics because it provides a more complete picture of the effectiveness and safety of health interventions. By using RWE, researchers can evaluate how interventions work in a variety of settings and patient populations, which can help inform clinical practice and policy decisions.

RWE can also be used to conduct cost-effectiveness analyses, which help policymakers determine the value of health interventions. Cost-effectiveness analyses compare the costs and benefits of different health interventions, taking into account the costs of the intervention as well as the costs of any adverse events or complications that may occur.

Differences between RWE and Randomized Controlled Trials (RCTs)

RCTs are considered the gold standard for evaluating the effectiveness and safety of health interventions. However, there are several key differences between RWE and RCTs.

RCTs are conducted under controlled conditions and have strict inclusion and exclusion criteria, which means that the results may not be generalizable to real-world populations. RWE, on the other hand, is collected from a variety of sources and reflects the real-world experiences of patients.

RCTs also tend to be shorter in duration than RWE studies, which means that they may not capture the long-term effects of health interventions. RWE studies, on the other hand, can provide information on the long-term effectiveness and safety of interventions.

Methods of Collecting RWE

There are several methods of collecting RWE, including:

Electronic Health Records (EHRs)
EHRs are digital records of patient health information that are maintained by healthcare providers. EHRs can provide a wealth of information on patient demographics, diagnoses, treatments, and outcomes.

Claims Databases
Claims databases contain information on healthcare services and medications that are billed to insurance providers. Claims data can provide information on healthcare utilization, costs, and outcomes.

Registries
Registries are databases that collect information on specific diseases or health conditions. They can provide valuable information on disease prevalence, treatment patterns, and outcomes.

Patient-Reported Outcomes (PROs)
PROs are questionnaires or surveys completed by patients that assess their health status, symptoms, and quality of life. PROs can provide information on patient preferences and experiences with different interventions.

Surveys
Surveys can be used to collect information on patient demographics, health behaviors, and healthcare utilization. They can also be used to assess patient preferences and satisfaction with different interventions.

Advantages of Real-World Evidence

There are several advantages of using RWE in health economics research, including:

  • RWE reflects real-world experiences and can provide a more comprehensive understanding of the effectiveness and safety of interventions.
  • RWE can be used to evaluate interventions in a variety of settings and patient populations.
  • RWE can provide information on the long-term effectiveness and safety of interventions.
  • RWE can be used to conduct cost-effectiveness analyses, which can inform clinical practice and policy decisions.

Challenges and Limitations of Real-World Evidence

There are several challenges and limitations to using RWE in health economics research, including:

  • RWE can be subject to bias and confounding, which can affect the validity of the results.
  • RWE can be difficult to collect and analyze, particularly when using multiple data sources.
  • RWE may not be as well-suited for evaluating rare diseases or interventions.

Applications of Real-World Evidence

RWE has several applications in health economics research, including:

Health Technology Assessment
Health technology assessment (HTA) is a process that evaluates the clinical effectiveness, safety, and cost-effectiveness of new health technologies. RWE can be used in HTA to provide information on the real-world effectiveness and safety of interventions.

Comparative Effectiveness Research
Comparative effectiveness research (CER) compares the effectiveness of different interventions for the same health condition. RWE can be used in CER to compare the effectiveness of interventions in different patient populations and settings.

Post-Marketing Surveillance
Post-marketing surveillance is the process of monitoring the safety and effectiveness of new drugs and medical devices after they have been approved for use. RWE can be used in post-marketing surveillance to monitor the long-term safety and effectiveness of interventions.

Future of Real-World Evidence in Health Economics

RWE is likely to become increasingly important in health economics research in the future. Advances in technology and data analytics are making it easier to collect and analyze RWE, and policymakers are recognizing the importance of using RWE to inform clinical practice and policy decisions.